Blueprint Medicines Corp
BPMC129.460USD
0.000
Close 11/25, 16:00（ET）Quotes delayed by 15 min
8.36BMarket Cap
LossP/E TTM
Blueprint Medicines Corp Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
508.82M
104.04%
EPS(YoY)
-1.07
87.25%
Analyst Rating
HOLD
2025-08-12
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its total revenue reached 508.82M, with a year-on-year change of 104.04%.
What is the Earnings Per Share (EPS) of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its Earnings Per Share (EPS) was -1.067, with a year-on-year change of 87.25%.
What is the net income of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its net income was -67.09M, with a year-on-year change of 86.77%.
What is the net margin of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its net profit margin was -13.19%, with a year-on-year change of 93.51%.
What is the gross margin of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its gross margin was 96.04%, with a year-on-year change of -0.56%.
What is the debt-to-asset ratio of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its debt-to-asset ratio was 32.80%, with a year-on-year change of 44.11%.
What is the Return on Equity (ROE) of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its Return on Equity (ROE) was -31.26%, with a year-on-year change of 80.11%.
What is the Return on Assets (ROA) of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its Return on Assets (ROA) was -6.02%, with a year-on-year change of 85.76%.
What is the operating profit of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its operating profit was -212.04M, with a year-on-year change of 56.39%.
What are the current assets of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its current assets were 742.68M, with a year-on-year change of -8.13%.
What are the total assets of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its total assets of Blueprint Medicines Corp were 1.18B, with a year-on-year change of 12.44%.
What are the total liabilities of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its total liabilities of Blueprint Medicines Corp were 881.15M, with a year-on-year change of -4.08%.
What is the total equity of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its total equity of Blueprint Medicines Corp was 298.67M, with a year-on-year change of 128.67%.
What is the net operating income of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its net operating income of Blueprint Medicines Corp was -67.09M, with a year-on-year change of 86.77%.
What is the net investment of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its net investment of Blueprint Medicines Corp was -47.50M, with a year-on-year change of -117.33%.
What is the net financing of Blueprint Medicines Corp?
According to Blueprint Medicines Corp's FY2024 earnings report, its net financing of Blueprint Medicines Corp was 273.11M, with a year-on-year change of 129.07%.
